Folgen
Ebba Sjögren
Titel
Zitiert von
Zitiert von
Jahr
Valuation studies? Our collective two cents
H Kjellberg, A Mallard, DL Arjaliès, P Aspers, S Beljean, A Bidet, A Corsin, ...
2172013
The Q (u) ALYfying hand: Health economics and medicine in the shaping of Swedish markets for subsidized pharmaceuticals
E Sjögren, CF Helgesson
The Sociological Review 55 (2_suppl), 215-240, 2007
992007
Valuation studies and the critique of valuation
L Doganova, M Giraudeau, CF Helgesson, H Kjellberg, F Lee, A Mallard, ...
Valuation Studies 2 (2), 87-96, 2014
892014
Valuation and Calculation at the Margins
A Mennicken, E Sjögren
Valuation Studies 3 (1), 1-7, 2015
602015
Reasonable drugs: Making decisions with ambiguous knowledge
E Sjögren
Economic Research Institute, Stockholm School of Economics (EFI)., 2006
472006
‘Accounting Talk’ Through Metaphorical Representations: Change Agents and Organisational Change in Home-Based Elderly Care
M Carlsson-Wall, K Kraus, M Lund, E Sjögren
European Accounting Review 25 (2), 215-243, 2016
432016
Glocal Pharma
E Johnson, E Sjögren, C Åsberg
Taylor & Francis, 2016
262016
No finish line: How formalization of academic assessment can undermine clarity and increase secrecy
KS Helgesson, E Sjögren
Gender, Work and Organization 26 (4), 558-581, 2019
242019
Accounting and professional work in established NPM settings
E Sjögren, K Fernler
Accounting, Auditing & Accountability Journal 32 (3), 897-922, 2019
182019
More Knowledge, Better Government? Consequences of Knowledge‐Based Decision Making in Swedish Pharmaceutical Benefits
ÅC Vifell, E Sjögren
Governance 24 (1), 85-110, 2011
172011
Five years! Have we not had enough of valuation studies by now?
L Doganova, M Giraudeau, H Kjellberg, CF Helgesson, F Lee, A Mallard, ...
Valuation Studies 5 (2), 83-91, 2018
152018
Decision usefulness explored: An investigation of capital market actors' use of financial reports
A Hjelstrom, T Hjelstrom, E Sjogren
Stockholm, Svenskt Naringsliv, 2014
15*2014
Identifying need through expressions of demand: Deciding on public financial intervention within the fields of healthcare and development aid
A Krohwinkel-Karlsson, E Sjögren
Routledge 10 (2), 197-220, 2008
152008
Deciding subsidy for pharmaceuticals based on ambiguous evidence
E Sjögren
Journal of health organization and management 22 (4), 368-383, 2008
142008
The legal mind of the internal market: A governmentality perspective on the judicialization of monitoring practices
ÅC Vifell, E Sjögren
JCMS: Journal of Common Market Studies 52 (3), 461-478, 2014
132014
Artful objects: Graham Harman on art and the business of speculative realism
I Nilson, E Wikberg
Sternberg Press; Stockholm School of Economics, 2020
72020
Role attribution in public sector accountability processes: Dynamic and situation-specific accountor and constituent roles
E Hagbjer, K Kraus, J Lind, E Sjögren
Qualitative Research in Accounting & Management 14 (4), 367-389, 2017
72017
Defining ‘markets’ for pharmaceuticals in Sweden: Public policy and commercialization
E Sjogren
Minerva 45 (2), 161-173, 2007
62007
Verktyg för att realisera samverkan: En vetenskaplig undersökning av TioHundraprojektet
E Sjögren, P Åhblom
På väg mot en värdefull styrning: Ersättningssystem för en sammanhållen vård …, 2012
5*2012
Democratic Priority Setting? Organizing Multiple Stakeholders to Make Decisions in the Healthcare Sector
E Sjögren, K Fernler
Organizing Democracy, 2010
52010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20